Announced Sat, 18 Jul · 13:15 IST
Compliance certificate under SEBI DP Regulations for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.6%1-day move
₹245.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+2.6+4.9+2.0+3.7+2.2—————
Up moveDown movePending
AI summary
Aptus Pharma has submitted to BSE a confirmation certificate from its Registrar and Share Transfer Agent, Accurate Securities and Registry Private Limited, under Regulation 74(5) of the SEBI Depositories and Participants Regulations 2018. The certificate covers the quarter ended 30 June 2026. Signed by Managing Director Tejash Hathi.
Likely market impact
No material impact. Routine quarterly regulatory compliance filing; no effect on operations or shareholders.